JOURNAL ISSUE published November 2007 in Expert Opinion on Drug Safety

Antiviral treatment of hepatitis C in renal transplant patients - safety issues

JOURNAL ARTICLE published 3 August 2017 in Expert Opinion on Drug Safety

Authors: Stella De Nicola | Massimo Colombo

Gliptins – do they increase cardiovascular risk or benefit?

JOURNAL ARTICLE published May 2014 in Expert Opinion on Drug Safety

Authors: Sheila A Doggrell | Simon B Dimmitt

Safety considerations when choosing the appropriate treatment for patients with multiple sclerosis

JOURNAL ARTICLE published October 2014 in Expert Opinion on Drug Safety

Authors: Angel P Sempere | Juana Gimenez-Martinez

Safety and risk communication to patients

JOURNAL ARTICLE published November 2006 in Expert Opinion on Drug Safety

Authors: Petra A Thürmann

Erythropoiesis-stimulating agents in patients with cancer: update on safety issues

JOURNAL ARTICLE published September 2009 in Expert Opinion on Drug Safety

Authors: Robert Pirker

Corrigendum

JOURNAL ARTICLE published 3 October 2017 in Expert Opinion on Drug Safety

Genetic alterations conferring resistance to hedgehog inhibitors in basal cell carcinoma

JOURNAL ARTICLE published 3 April 2022 in Expert Opinion on Drug Safety

Authors: Harrison Zhu | Daniel J. Lewis

Related articles

JOURNAL ARTICLE published April 2014 in Expert Opinion on Drug Safety

The safety of obesity drugs – authors' response

JOURNAL ARTICLE published September 2007 in Expert Opinion on Drug Safety

Authors: Frank Greenway | Mary Katherine Caruso

The safety of bevacizumab

JOURNAL ARTICLE published March 2006 in Expert Opinion on Drug Safety

Authors: Rachel E Sanborn | Alan B Sandler

Gastrointestinal side effects of drugs

JOURNAL ARTICLE published July 2003 in Expert Opinion on Drug Safety

Authors: Richard Makins | Anne Ballinger

Celecoxib and cardiovascular risks

JOURNAL ARTICLE published November 2005 in Expert Opinion on Drug Safety

Authors: James M Brophy

Varenicline use in patients with mental illness: an update of the evidence

JOURNAL ARTICLE published May 2010 in Expert Opinion on Drug Safety

Authors: Tara L Purvis | Leigh Anne Nelson | Scott E Mambourg

Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines

JOURNAL ARTICLE published 2 November 2021 in Expert Opinion on Drug Safety

Authors: Maurizio Sessa | Kristian Kragholm | Anders Hviid | Morten Andersen

Adverse events associated with somatostatin analogs in acromegaly

JOURNAL ARTICLE published 3 August 2015 in Expert Opinion on Drug Safety

Authors: Ludovica FS Grasso | Renata S Auriemma | Rosario Pivonello | Annamaria Colao

Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety

JOURNAL ARTICLE published 2 November 2022 in Expert Opinion on Drug Safety

Research funded by Agency for HealthCare Research and Quality (R18HS027277) | Australian National Health and Medical Research Council (NHMRC) Investigator (GNT1195460 to ER)

Authors: Annesha White | Kimberly G. Fulda | Rachel Blythe | Michelle A. Chui | Emily Reeve | Richard Young | Anna Espinoza | Noah Hendrix | Yan Xiao

Sodium nitroprusside induced cyanide toxicity in pediatric patients

JOURNAL ARTICLE published September 2009 in Expert Opinion on Drug Safety

Authors: Christopher Thomas | Lindsay Svehla | Brady S Moffett

Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions

JOURNAL ARTICLE published 2 September 2021 in Expert Opinion on Drug Safety

Authors: Athanasios Tragiannidis | Anastasia Gkampeta | Maria Vousvouki | Eleni Vasileiou | Andreas H. Groll

Strategies for more effective and reliable ADME

JOURNAL ARTICLE published July 2004 in Expert Opinion on Drug Safety

Authors: Slobodan Rendic